These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8200854)

  • 1. Active efflux system for cisplatin in cisplatin-resistant human KB cells.
    Fujii R; Mutoh M; Niwa K; Yamada K; Aikou T; Nakagawa M; Kuwano M; Akiyama S
    Jpn J Cancer Res; 1994 Apr; 85(4):426-33. PubMed ID: 8200854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine triphosphate-dependent transport of leukotriene C4 by membrane vesicles prepared from cisplatin-resistant human epidermoid carcinoma tumor cells.
    Fujii R; Mutoh M; Sumizawa T; Chen ZS; Yoshimura A; Akiyama S
    J Natl Cancer Inst; 1994 Dec; 86(23):1781-4. PubMed ID: 7966417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An active efflux system for heavy metals in cisplatin-resistant human KB carcinoma cells.
    Chen ZS; Mutoh M; Sumizawa T; Furukawa T; Haraguchi M; Tani A; Saijo N; Kondo T; Akiyama S
    Exp Cell Res; 1998 May; 240(2):312-20. PubMed ID: 9597004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the ATP-dependent LTC4 transporter in cisplatin-resistant human KB cells.
    Chuman Y; Chen ZS; Sumizawa T; Furukawa T; Haraguchi M; Takebayashi Y; Niwa K; Yamada K; Aikou T; Akiyama S
    Biochem Biophys Res Commun; 1996 Sep; 226(1):158-65. PubMed ID: 8806607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of NF-κB activation in the cisplatin resistance of human epidermoid carcinoma KCP-4 cells.
    Oiso S; Ikeda R; Nakamura K; Takeda Y; Akiyama S; Kariyazono H
    Oncol Rep; 2012 Jul; 28(1):27-32. PubMed ID: 22562377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors involved in the cisplatin resistance of KCP‑4 human epidermoid carcinoma cells.
    Oiso S; Takayama Y; Nakazaki R; Matsunaga N; Motooka C; Yamamura A; Ikeda R; Nakamura K; Takeda Y; Kariyazono H
    Oncol Rep; 2014 Feb; 31(2):719-26. PubMed ID: 24317338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced nucleotide excision repair in cisplatin resistant human KB carcinoma cells.
    Mukai M; Kanzaki A; Chen ZS; Miyashita H; Sumizawa T; Furukawa T; Haraguchi M; Takebayashi Y; Takamatsu H; Akiyama S
    Oncol Rep; 2002; 9(4):839-44. PubMed ID: 12066219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An enhanced active efflux of CPT-11 and SN-38 in cisplatin-resistant human KB carcinoma cells.
    Chen ZS; Sumizawa T; Furukawa T; Ono K; Tani A; Komatsu M; Akiyama S
    Cancer Lett; 1999 Apr; 138(1-2):13-22. PubMed ID: 10378768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells.
    Chiang CD; Song EJ; Yang VC; Chao CC
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):759-64. PubMed ID: 7914401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance.
    Komatsu M; Sumizawa T; Mutoh M; Chen ZS; Terada K; Furukawa T; Yang XL; Gao H; Miura N; Sugiyama T; Akiyama S
    Cancer Res; 2000 Mar; 60(5):1312-6. PubMed ID: 10728692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased efflux of vincristine, but not of daunorubicin, associated with the murine multidrug resistance protein (MRP).
    Slapak CA; Martell RL; Terashima M; Levy SB
    Biochem Pharmacol; 1996 Nov; 52(10):1569-76. PubMed ID: 8937472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).
    Ohmori T; Morikage T; Sugimoto Y; Fujiwara Y; Kasahara K; Nishio K; Ohta S; Sasaki Y; Takahashi T; Saijo N
    Jpn J Cancer Res; 1993 Jan; 84(1):83-92. PubMed ID: 8383649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
    Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-resistance to cis-diamminedichloroplatinum(II) of a multidrug-resistant lymphoma cell line associated with decreased drug accumulation and enhanced DNA repair.
    Chao CC
    Eur J Pharmacol; 1996 Jun; 305(1-3):213-22. PubMed ID: 8813556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased accumulation of [14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake.
    Shen DW; Goldenberg S; Pastan I; Gottesman MM
    J Cell Physiol; 2000 Apr; 183(1):108-16. PubMed ID: 10699972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the glycoform of cisplatin-resistant human carcinoma cells are caused by defects in the endoplasmic reticulum-associated degradation system.
    Nakagawa H; Ohira M; Hayashi S; Abe S; Saito S; Nagahori N; Monde K; Shinohara Y; Fujitani N; Kondo H; Akiyama S; Nakagawara A; Nishimura S
    Cancer Lett; 2008 Nov; 270(2):295-301. PubMed ID: 18573595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.
    Andrews PA; Velury S; Mann SC; Howell SB
    Cancer Res; 1988 Jan; 48(1):68-73. PubMed ID: 3335000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in biophysical parameters of plasma membranes influence cisplatin resistance of sensitive and resistant epidermal carcinoma cells.
    Liang XJ; Yin JJ; Zhou JW; Wang PC; Taylor B; Cardarelli C; Kozar M; Forte R; Aszalos A; Gottesman MM
    Exp Cell Res; 2004 Feb; 293(2):283-91. PubMed ID: 14729466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codominance of cisplatin resistance in somatic cell hybrids.
    Ying YL; Shen DW; Liang XJ; Gottesman MM
    J Cell Physiol; 2003 Jul; 196(1):63-9. PubMed ID: 12767041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cisplatin sensitivity and accumulation by amphotericin B in cisplatin-resistant human lung cancer cell lines.
    Morikage T; Ohmori T; Nishio K; Fujiwara Y; Takeda Y; Saijo N
    Cancer Res; 1993 Jul; 53(14):3302-7. PubMed ID: 8391922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.